These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2196425)

  • 41. Regulatory developmental neurotoxicity and human risk assessment.
    Francis EZ
    Neurotoxicology; 1992; 13(1):77-84. PubMed ID: 1508435
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An assessment of the developmental, reproductive, and neurotoxicity of endosulfan.
    Silva MH; Gammon D
    Birth Defects Res B Dev Reprod Toxicol; 2009 Feb; 86(1):1-28. PubMed ID: 19243027
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhalation developmental neurotoxicity study of ethylbenzene in Crl-CD rats.
    Faber WD; Roberts LS; Stump DG; Beck M; Kirkpatrick D; Regan KS; Tort M; Moran E; Banton M
    Birth Defects Res B Dev Reprod Toxicol; 2007 Feb; 80(1):34-48. PubMed ID: 17294454
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Profiling the activity of environmental chemicals in prenatal developmental toxicity studies using the U.S. EPA's ToxRefDB.
    Knudsen TB; Martin MT; Kavlock RJ; Judson RS; Dix DJ; Singh AV
    Reprod Toxicol; 2009 Sep; 28(2):209-19. PubMed ID: 19446433
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Undertaking positive control studies as part of developmental neurotoxicity testing: a report from the ILSI Research Foundation/Risk Science Institute expert working group on neurodevelopmental endpoints.
    Crofton KM; Foss JA; Hass U; Jensen KF; Levin ED; Parker SP
    Neurotoxicol Teratol; 2008; 30(4):266-87. PubMed ID: 17681747
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of exposure period and nutrition on the developmental neurotoxicity of anticonvulsants in rats: short and long-term effects.
    Vorhees CV; Rindler JM; Minck DR
    Neurotoxicology; 1990; 11(2):273-83. PubMed ID: 2234544
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Approaches to evaluating reproductive hazards and risks.
    Kimmel CA
    Environ Health Perspect; 1993 Jul; 101 Suppl 2(Suppl 2):137-43. PubMed ID: 8243384
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exclusive prenatal exposure to a 16 PAH mixture does not impact anxiety-related behaviours and regional brain metabolism in adult male rats: a role for the period of exposure in the modulation of PAH neurotoxicity.
    Crépeaux G; Bouillaud-Kremarik P; Sikhayeva N; Rychen G; Soulimani R; Schroeder H
    Toxicol Lett; 2013 Jul; 221(1):40-6. PubMed ID: 23742931
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multigenerational reproductive study of genistein (Cas No. 446-72-0) in Sprague-Dawley rats (feed study).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2008 Mar; (539):1-266. PubMed ID: 18685713
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Application of in vitro neurotoxicity testing for regulatory purposes: Symposium III summary and research needs.
    Bal-Price AK; Suñol C; Weiss DG; van Vliet E; Westerink RH; Costa LG
    Neurotoxicology; 2008 May; 29(3):520-31. PubMed ID: 18417220
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Determining normal variability in a developmental neurotoxicity test: a report from the ILSI Research Foundation/Risk Science Institute expert working group on neurodevelopmental endpoints.
    Raffaele KC; Fisher JE; Hancock S; Hazelden K; Sobrian SK
    Neurotoxicol Teratol; 2008; 30(4):288-325. PubMed ID: 18280700
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro techniques for the assessment of neurotoxicity.
    Harry GJ; Billingsley M; Bruinink A; Campbell IL; Classen W; Dorman DC; Galli C; Ray D; Smith RA; Tilson HA
    Environ Health Perspect; 1998 Feb; 106 Suppl 1(Suppl 1):131-58. PubMed ID: 9539010
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Strategies and tools for preventing neurotoxicity: to test, to predict and how to do it.
    Llorens J; Li AA; Ceccatelli S; Suñol C
    Neurotoxicology; 2012 Aug; 33(4):796-804. PubMed ID: 22342764
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Methods to identify and characterize developmental neurotoxicity for human health risk assessment. III: pharmacokinetic and pharmacodynamic considerations.
    Dorman DC; Allen SL; Byczkowski JZ; Claudio L; Fisher JE; Fisher JW; Harry GJ; Li AA; Makris SL; Padilla S; Sultatos LG; Mileson BE
    Environ Health Perspect; 2001 Mar; 109 Suppl 1(Suppl 1):101-11. PubMed ID: 11250810
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interpretation and application of delayed neurotoxicity test data from regulatory and legal viewpoints: panel discussion.
    Rosenstein LS; Maddy KT; Sette WF; Mendoza CE; Beyer SV
    Neurotoxicology; 1983; 4(4):85-97. PubMed ID: 6686874
    [No Abstract]   [Full Text] [Related]  

  • 56. Analysis of reproductive toxicity and classification of glufosinate-ammonium.
    Schulte-Hermann R; Wogan GN; Berry C; Brown NA; Czeizel A; Giavini E; Holmes LB; Kroes R; Nau H; Neubert D; Oesch F; Ott T; Pelkonen O; Robert-Gnansia E; Sullivan FM
    Regul Toxicol Pharmacol; 2006 Apr; 44(3 Suppl 1):S1-76. PubMed ID: 16510221
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Developmental neurotoxicity of carbon monoxide.
    Carratu MR; Cagiano R; De Salvia MA; Trabace L; Cuomo V
    Arch Toxicol Suppl; 1995; 17():295-301. PubMed ID: 7786165
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of developmental toxicity data: a discussion of some pertinent factors and a proposal.
    Hart WL; Reynolds RC; Krasavage WJ; Ely TS; Bell RH; Raleigh RL
    Risk Anal; 1988 Mar; 8(1):59-69. PubMed ID: 3287508
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Testing for cognitive function in animals in a regulatory context.
    Bushnell PJ
    Neurotoxicol Teratol; 2015; 52(Pt A):68-77. PubMed ID: 24815542
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.